The Bull Case for Vertex Pharmaceuticals (VRTX) Could Change Following Strong Kidney Data and Regulatory Progress

Vertex Pharmaceuticals recently presented updated interim data at the 2025 ASN Kidney Week, revealing significant proteinuria ...

Vertex (VERX) Valuation Discount and 82.67% Earnings Growth Forecast Highlight Optimistic Sentiment

Vertex (VERX) remains unprofitable but is narrowing its losses at an average rate of 16.4% per year over the past five years. Looking ahead, the company’s annual revenue is expected to grow by 12.4% ...

Barclays Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX)

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Vertex Pharmaceuticals (NASDAQ:VRTX) Reports Q3 In Line With Expectations

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Farkas has the votes to repeal blanket rezoning in Calgary; some hope for a middle ground

Blanket rezoning was a wedge issue during Calgary's recent municipal election. Many candidates pledged to repeal and return to the previous zoning regime. But with other councillors looking for major ...